English

Tekbiotech-Yeast Display Service,Phage display technology
Home / Targeted Peptide Discovery Technology Service

目录&服务

Inquiry and ordering

  • Name*

  • Phone*

  • Email*

  • Product*

  • Content*

Targeted Peptide Discovery Technology Service

Based on its experienced phage surface display technology, TekBiotech provides targeted peptide discovery services to global customers. Different from the well-known recombinant M13 phage display technology, the M13 peptide surface display technology provided by TekBiotech is to modify the wild-type M13 phage and insert the random peptide sequence into the N-terminus of the P3 protein of the wild-type M13 phage through gene editing engineering, so that the random peptide is displayed on the surface of the wild-type M13 phage along with the expression of the coat protein, and then the targeted peptide is screened through a simple blue-white screening system.


█ Targeted Peptide Development Service Based On Phage Display Technology


TekBiotech adopts modular design principles and provides customers with a very convenient service form: customers can customize each module at will and choose any module to start the project, as shown in Figure 1, the different modules of the M13 phage display system:


  Targeted Peptide Discovery Technology Service-tekbiotech1.png

Figure1 M13 phage targeted peptide development process based on phage technology platform

 

Therefore, TeKBiotech's targeted peptide development technology includes:


Cyclic peptide display library construction service

Linear peptide display library construction service

Bicyclic peptide library display library construction service

In vitro peptide screening technology service

In vivo animal screening technology service

 


█ Targeted Peptide Discovery Technology Platform Service Advantages

 

Targeted Peptide Discovery Technology Service-tekbiotech2.pngTargeted Peptide Discovery Technology Service-tekbiotech3.pngTargeted Peptide Discovery Technology Service-tekbiotech4.pngTargeted Peptide Discovery Technology Service-tekbiotech5.png


Short development cycle: 2-3 weeks 

(pre-made peptide library)


Low false positive, blue-white system, no 

need for auxiliary phage and ELISA 

verification


Large library capacity, high 

screening success rate


Flexible library screening methods: solid phase 

screening, liquid phase screening, cell screening, 

in vivo screening



*
*
*
*

×

Targeted Peptide Discovery Technology Service Frequently Asked Questions

Consult Now Targeted Peptide Discovery Technology Service

*
*
*
*
*
*
*
• For a detailed understanding of customer information protection, please visit Privacy Policy
• If you have any questions about our technical services, you can send an email to info@tekbiotech.com Or make a phone call 400-168-8285 Detailed Consultation。

To experience the reliable service of Tekbiotech please subscribe: